Literature DB >> 32357804

Bench-to-bedside translation of interleukin-15 for immunotherapy: principles and challenges.

Chalet Tan1, Thomas A Waldmann2.   

Abstract

Entities:  

Year:  2020        PMID: 32357804      PMCID: PMC7374014          DOI: 10.1080/17425247.2020.1764933

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


× No keyword cloud information.
  33 in total

1.  ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.

Authors:  John M Wrangle; Vamsidhar Velcheti; Manish R Patel; Elizabeth Garrett-Mayer; Elizabeth G Hill; James G Ravenel; Jeffrey S Miller; Mohammad Farhad; Kate Anderton; Kathryn Lindsey; Michele Taffaro-Neskey; Carol Sherman; Samantha Suriano; Marzena Swiderska-Syn; Amy Sion; Joni Harris; Andie R Edwards; Julie A Rytlewski; Catherine M Sanders; Erik C Yusko; Mark D Robinson; Carsten Krieg; William L Redmond; Jack O Egan; Peter R Rhode; Emily K Jeng; Amy D Rock; Hing C Wong; Mark P Rubinstein
Journal:  Lancet Oncol       Date:  2018-04-05       Impact factor: 41.316

2.  Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Authors:  Kevin C Conlon; Enrico Lugli; Hugh C Welles; Steven A Rosenberg; Antonio Tito Fojo; John C Morris; Thomas A Fleisher; Sigrid P Dubois; Liyanage P Perera; Donn M Stewart; Carolyn K Goldman; Bonita R Bryant; Jean M Decker; Jing Chen; Tat'Yana A Worthy; William D Figg; Cody J Peer; Michael C Sneller; H Clifford Lane; Jason L Yovandich; Stephen P Creekmore; Mario Roederer; Thomas A Waldmann
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

Review 3.  In situ forming injectable hydrogels for drug delivery and wound repair.

Authors:  Robert Dimatteo; Nicole J Darling; Tatiana Segura
Journal:  Adv Drug Deliv Rev       Date:  2018-03-19       Impact factor: 15.470

Review 4.  Cytokine control of memory T-cell development and survival.

Authors:  Kimberly S Schluns; Leo Lefrançois
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 5.  Interleukin-2, interleukin-15, and their roles in human natural killer cells.

Authors:  Brian Becknell; Michael A Caligiuri
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

6.  Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling.

Authors:  Louise M D'Cruz; Ludger Klein
Journal:  Nat Immunol       Date:  2005-10-16       Impact factor: 25.606

Review 7.  The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.

Authors:  Thomas A Waldmann
Journal:  Nat Rev Immunol       Date:  2006-08       Impact factor: 53.106

8.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Authors:  K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

9.  Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.

Authors:  Ruth Ladenstein; Ulrike Pötschger; Dominique Valteau-Couanet; Roberto Luksch; Victoria Castel; Isaac Yaniv; Genevieve Laureys; Penelope Brock; Jean Marie Michon; Cormac Owens; Toby Trahair; Godfrey Chi Fung Chan; Ellen Ruud; Henrik Schroeder; Maja Beck Popovic; Guenter Schreier; Hans Loibner; Peter Ambros; Keith Holmes; Maria Rita Castellani; Mark N Gaze; Alberto Garaventa; Andrew D J Pearson; Holger N Lode
Journal:  Lancet Oncol       Date:  2018-11-12       Impact factor: 41.316

10.  Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer.

Authors:  Thomas A Waldmann; Milos D Miljkovic; Kevin C Conlon
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

View more
  1 in total

Review 1.  Exploiting protease activation for therapy.

Authors:  Chloe Bleuez; Wolfgang F Koch; Carole Urbach; Florian Hollfelder; Lutz Jermutus
Journal:  Drug Discov Today       Date:  2022-03-18       Impact factor: 8.369

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.